A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
CREO MEDICAL GROUP PLC ORD GBP0 operates in the Medical - Devices industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Revenue | 95M | 95M | 85M | 47M |
| Net Income | 8.9M | 8.9M | 7.5M | 1.7M |
| EPS | $0.07 | $0.07 | $0.06 | $0.02 |
| Free Cash Flow | 8.6M | 8.6M | 12M | 9.2M |
| ROIC | 14.1% | 11.7% | 15.8% | 4.9% |
| Gross Margin | 48.3% | 48.3% | 50.7% | 47.4% |
| Debt/Equity | 0.00 | 0.17 | 0.10 | 0.46 |
| Dividends/Share | $0.03 | $0.03 | $0.04 | $0.01 |
| Operating Income | 10M | 10M | 12M | 3.1M |
| Operating Margin | 11.0% | 11.0% | 13.8% | 6.4% |
| ROE | 11.8% | 11.8% | 12.3% | 3.7% |
| Shares Outstanding | 122M | 122M | 120M | 111M |
| Metric | 2020 | 2021 | 2022 | TTM |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 47M | 85M | 95M | 95M |
| Gross Margin | 47.4% | 50.7% | 48.3% | 48.3% |
| R&D | N/A | N/A | N/A | N/A |
| SG&A | 19M | 31M | 35M | 35M |
| EBIT | 3.1M | 12M | 10M | 10M |
| Op. Margin | 6.4% | 13.8% | 11.0% | 11.0% |
| Net Income | 1.7M | 7.5M | 8.9M | 8.9M |
| Net Margin | 3.7% | 8.8% | 9.4% | 9.4% |
| Non-Recurring | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||
| ROIC | 4.9% | 15.8% | 11.7% | 14.1% |
| ROE | 3.7% | 12.3% | 11.8% | 11.8% |
| ROA | 2.0% | 7.6% | 8.1% | 8.3% |
| Cash Flow | ||||
| Op. Cash Flow | 11M | 13M | 11M | 11M |
| Free Cash Flow | 9.2M | 12M | 8.6M | 8.6M |
| Owner Earnings | 11M | 12M | 8.7M | 8.7M |
| CapEx | 1.9M | 1.8M | 2.2M | 2.2M |
| Maint. CapEx | 0 | 0 | 0 | 0 |
| Growth CapEx | N/A | N/A | N/A | 2.2M |
| D&A | 0 | 0 | 0 | 0 |
| CapEx/OCF | 17.1% | 13.5% | 20.3% | 20.3% |
| Capital Allocation | ||||
| Dividends Paid | 1.2M | 4.4M | 4.1M | 4.1M |
| Dividend Yield | 0.5% | 1.4% | 3.1% | 0.3% |
| Share Buybacks | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | 271K | 937K | 2.1M | 2.1M |
| Debt Repayment | 70K | 32M | 4.9M | 4.9M |
| Balance Sheet | ||||
| Net Debt | 3.5M | -5.3M | -969K | -14M |
| Cash & Equiv. | 18M | 13M | 14M | 14M |
| Long-Term Debt | N/A | 0 | 7.0M | 7.0M |
| Debt/Equity | 0.46 | 0.10 | 0.17 | 0.00 |
| Interest Coverage | 6.4 | 7.5 | 10.1 | 10.1 |
| Equity | 47M | 75M | 75M | 75M |
| Total Assets | 87M | 112M | 106M | 106M |
| Total Liabilities | 40M | 36M | 31M | 31M |
| Intangibles | N/A | 31M | 26M | 26M |
| Retained Earnings | 28M | 34M | 37M | 37M |
| Working Capital | 10M | 2.9M | 14M | 14M |
| Current Assets | 29M | 33M | 35M | 35M |
| Current Liabilities | 18M | 30M | 21M | 21M |
| Per Share Data | ||||
| EPS | 0.02 | 0.06 | 0.07 | 0.07 |
| Owner EPS | 0.10 | 0.10 | 0.07 | 0.07 |
| Book Value | 0.42 | 0.63 | 0.61 | 0.61 |
| Cash Flow/Share | 0.10 | 0.11 | 0.09 | 0.07 |
| Dividends/Share | 0.01 | 0.04 | 0.03 | 0.03 |
| Shares Out. | 111.2M | 119.9M | 122.4M | 122.4M |
| Valuation | ||||
| P/E Ratio | 154.7 | 30.1 | 4.6 | 163.5 |
| P/FCF | 29.0 | 19.3 | 4.7 | 167.4 |
| EV/EBIT | 88.9 | 18.6 | 3.8 | 136.7 |
| Price/Book | 5.7 | 3.0 | 0.5 | 19.1 |
| Price/Sales | 5.7 | 2.6 | 0.4 | 15.2 |
| FCF Yield | 3.4% | 5.2% | 21.1% | 0.6% |
| Market Cap | 268M | 223M | 41M | 1.4B |
| Avg. Price | 2.09 | 2.53 | 1.08 | 11.75 |
| Year-End Price | 2.41 | 1.86 | 0.33 | 11.75 |
CREO MEDICAL GROUP PLC ORD GBP0 passes 3 of 9 quality checks, indicating weak fundamentals.
CREO MEDICAL GROUP PLC ORD GBP0 trades at 163.4x trailing earnings, compared to its 15-year median P/E of 17.4x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 167.4x vs a median of 19.3x. The company's 5-year average ROIC is 10.8% with a gross margin of 48.8%. Total shareholder yield (dividends) is 0.3%. At current prices, the estimated annualized return to fair value is -3.4%.
CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) has a current P/E ratio of 163.4, compared to its historical median P/E of 17.4. The stock is currently considered Expensive based on its historical valuation range.
CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) has a 5-year average return on invested capital (ROIC) of 10.8%. This indicates solid capital allocation.
CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) has a market capitalization of $1.4B. It is classified as a small-cap stock.
Yes, CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) pays a dividend with a trailing twelve-month yield of 0.29%.
Based on historical P/E analysis, CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) appears expensive. The current P/E of 163.4 is 841% above its historical median of 17.4. The estimated fair value CAGR (P/E method) is 34.8%.
CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) operates in the Medical - Devices industry, within the Healthcare sector.
CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) reported annual revenue of $95 million in its most recent fiscal year, based on SEC EDGAR filings.
CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) has a net profit margin of 9.4%. This is a modest margin.
CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) generated $9 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) has a debt-to-equity ratio of 0.17. This indicates a conservatively financed balance sheet.
CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) reported earnings per share (EPS) of $0.07 in its most recent fiscal year.
CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) has a return on equity (ROE) of 11.8%. This indicates moderate shareholder returns.
CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) has a 5-year average gross margin of 48.8%. This indicates decent pricing power.
The Ledger Terminal provides 3 years of financial data for CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
CREO MEDICAL GROUP PLC ORD GBP0 (CREO-L) has a book value per share of $0.61, based on its most recent annual SEC filing.
No recent press releases.